AI Bias Analysis
4 models · Takes ~15 seconds
How thin science fuels peptide hype, blowback to proposed NIH cuts, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab
A small biotech was forced to being winding down its operations after the FDA abruptly postponed a key meeting for four months
(MedPage Today) -- Note that some links may require registration or subscription. Certain lots of Christopher Ranch and Garland-branded peeled garlic have been recalled over possible botulism risk, according to an FDA notice. Supreme Court Justice...
A hep B trial raises ethical questions, the peptide hype, and more Morning Rounds news
Neurocrine Biosciences is buying Soleno Therapeutics for $2.9 billion, picking up an approved medicine for a rare disease that causes insatiable hunger.